KIM, TAE KYUNG,WOO, JUNG WON,LEE, JOAN YOON JI,AHN, YOUNG-JOO,CHA, JI-EUN,RHIM, HYOU YOUNG,JANG, WOO ICK
申请号：
CA3034240
公开号：
CA3034240A1
申请日:
2017.08.30
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present disclosure relates to a method for administering a human growth hormone fusion protein (GX-H9) for treating growth hormone deficiency. Specifically, the present disclosure relates to a pharmaceutical composition for treating growth hormone deficiency, which comprises an hGH fusion protein (GX-H9) and a pharmaceutically acceptable carrier, wherein the fusion protein (GX-H9) is administered once a week at a dose of 0.4 to 1.6 mg per body weight kg of a pediatric patient, or administered once every two weeks at a dose of 0.8 to 3.2 mg per body weight kg of a pediatric patient. In addition, the present disclosure relates to a method for treating growth hormone deficiency, which comprising a step of administering an hGH fusion protein (GX-H9) to a patient with growth hormone deficiency once a week at a dose of 0.4 to 1.6 mg per body weight kg of the patient, or once every two weeks at a dose of 0.8 to 3.2 mg per body weight kg of the patient.
